Advanced glycation end products elicit externalization of phosphatidylserine in a subpopulation of platelets via 5-HT 2 A / 2 C receptors

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction

  2005cited by this paper
• Cardiovascular risk in patients with end-stage renal disease: a potential role for advanced glycation end products.

  2005cited by this paper
• The role of AGEs and AGE inhibitors in diabetic cardiovascular disease.

  2005cited by this paper
• Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.

  2005cited by this paper
• Serotonin-mediated phosphorylation of extracellular regulated kinases in platelets of patients with panic disorder versus controls.

  2004cited by this paper
• Peptide and amino acid glycation: new insights into the Maillard reaction

  2004cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus

  2003cited by this paper
• Role of protein kinase C in BSA-AGE-mediated inducible nitric oxide synthase expression in RAW 264.7 macrophages.

  2003cited by this paper
• Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

  2003cited by this paper
• Serotonin-induced MMP-13 Production Is Mediated via Phospholipase C, Protein Kinase C, and ERK1/2 in Rat Uterine Smooth Muscle Cells*

  2002cited by this paper
• Platelets and thrombin generation.

  2002cited by this paper
• Haemodialysis, atherosclerosis and inflammation-identifying molecular mechanisms of chronic vascular disease in ESDR patients.

  2002cited by this paper
• Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells.

  2001cited by this paper
• Increased platelet and erythrocyte external cell membrane phosphatidylserine in type 1 diabetes and microalbuminuria.

  2001cited by this paper
• Spontaneous Neutrophil Apoptosis Involves Caspase 3-mediated Activation of Protein Kinase C-δ*

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

  1999cited by this paper
• Role of caspase in a subset of human platelet activation responses.

  1999cited by this paper
• Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.

  1999cited by this paper
• Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation.

  1999cited by this paper
• Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors*

  1998cited by this paper
• Increased aggregation of human platelets produced by advanced glycation end products in vitro.

  1998cited by this paper
• Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.

  1997cited by this paper
• Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation.

  1997cited by this paper
• Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes.

  1996cited by this paper
• Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.

  1993cited by this paper
• Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C.

  1993cited by this paper
• The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

  1991cited by this paper
• Analysis of serial measurements in medical research.

  1990cited by this paper
• 5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues.

  1986cited by this paper
• Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder.

  1985cited by this paper

• Advanced Glycation End Products: key player of the pathogenesis of atherosclerosis

  2022cites this paper
• Nonenzymatic Reactions above Phospholipid Surfaces of Biological Membranes: Reactivity of Phospholipids and Their Oxidation Derivatives

  2015cites this paper